Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), Celgene Corporation (NASDAQ:CELG), Health Management Associates Inc (NYSE:HMA)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) managed to keep its gain at 1.73% on below -normal volume of 2.83M shares. The stock settled at $18.80 after floating in a range of $18.44 to $19.18. Its latest price has reached market capitalization of $3.48 billion. Its 52-week range has been $15.35 to $25.40. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients.
For How Long ARIA will fight for Profitability? Read This Trend Analysis report
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) traded up on a volume of 2.80 million, higher than its standard daily volume. Shares have gained 5.26% to $3. Over the last twelve months, the stock has gained 28.76% and faced a worst price of $1.60. Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers.
For How Long ONCY’s Gloss will Attract Investors? Find out via this report
Celgene Corporation (NASDAQ:CELG) settled 3.05% higher at $157.27 on above-normal volume of 2.73M shares during the last trading day. The stock has its 12-month high at $157.95 and 52-week low price was $71.23. It traded in a range of $152.88 to $157.95 during the last trading day. Celgene Corporation discovers, develops, and commercializes therapies for cancer and immune-inflammatory related diseases in the United States and Europe.
Why Should Investors Buy CELG After the Recent Fall? Just Go Here and Find Out
In the last trading session, Health Management Associates Inc (NYSE:HMA) was up on low volume, trading at a volume of 2.70M versus its average daily volume of 3.90 million shares. At $13, the stock has attained market capitalization of 3.38 billion. Health Management Associates, Inc., through its subsidiaries, engages in the operation of general acute care hospitals and other health care facilities in non-urban communities in the United States.
Will HMA Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)